We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$18.7B
AUM Growth
+$1.89B
Cap. Flow
+$1.31B
Cap. Flow %
7.02%
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$176M
2
KO icon
Coca-Cola
KO
+$151M
3
AVGO icon
Broadcom
AVGO
+$146M
4
MSFT icon
Microsoft
MSFT
+$140M
5
XOM icon
ExxonMobil
XOM
+$137M

Sector Composition

Rank Sector Weight
1 Technology 16.93%
2 Industrials 11.65%
3 Consumer Discretionary 11.56%
4 Healthcare 11.56%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFSW
2051
DELISTED
PFSweb, Inc.
PFSW
$79.9K ﹤0.01%
+12,997
New +$121K
IGHG icon
2052
ProShares Investment Grade-Interest Rate Hedged
IGHG
$328M
$79.6K ﹤0.01%
1,120
PRLD icon
2053
Prelude Therapeutics
PRLD
$359M
$79.3K ﹤0.01%
+13,127
New +$84.1K
FM
2054
DELISTED
iShares Frontier and Select EM ETF
FM
$79.2K ﹤0.01%
3,110
+2,430
+357% +$60.2K
ESGD icon
2055
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
$78.8K ﹤0.01%
+1,198
New +$75.2K
VCR icon
2056
Vanguard Consumer Discretionary ETF
VCR
$5.99B
$78.6K ﹤0.01%
359
-2,066
-85% -$484K
QRHC icon
2057
Quest Resource Holding
QRHC
$27.8M
$78.2K ﹤0.01%
+12,801
New +$95.5K
GTX icon
2058
Garrett Motion
GTX
$5.59B
$77.6K ﹤0.01%
+10,187
New +$71.6K
PDN icon
2059
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$348M
$76.8K ﹤0.01%
+2,594
New +$73.2K
SHPH icon
2060
Shuttle Pharmaceuticals
SHPH
$1.56M
$76.6K ﹤0.01%
20
PTF icon
2061
Invesco Dorsey Wright Technology Momentum ETF
PTF
$536M
$76.2K ﹤0.01%
2,016
+1,716
+572% +$65.7K
FPXI icon
2062
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$263M
$76.1K ﹤0.01%
1,959
-2,175
-53% -$81.5K
III icon
2063
Information Services Group
III
$203M
$75.8K ﹤0.01%
+16,488
New +$83.3K
AUPH icon
2064
Aurinia Pharmaceuticals
AUPH
$1.92B
$75.8K ﹤0.01%
+17,545
New +$102K
RNAC icon
2065
Cartesian Therapeutics
RNAC
$224M
$75.8K ﹤0.01%
2,235
+235
+12% +$10K
RLGT icon
2066
Radiant Logistics
RLGT
$401M
$75.6K ﹤0.01%
+14,859
New +$83.3K
PRFZ icon
2067
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.75B
$75.4K ﹤0.01%
2,380
-1,495
-39% -$47.9K
USRT icon
2068
iShares Core US REIT ETF
USRT
$4.72B
$75.2K ﹤0.01%
1,521
-187
-11% -$9.27K
BBH icon
2069
VanEck Biotech ETF
BBH
$410M
$74.9K ﹤0.01%
469
-577
-55% -$91.4K
SPDN icon
2070
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$224M
$74.8K ﹤0.01%
4,532
+2,445
+117% +$40.5K
FDVV icon
2071
Fidelity High Dividend ETF
FDVV
$10.2B
$74.7K ﹤0.01%
2,002
-17,572
-90% -$644K
PKB icon
2072
Invesco Building & Construction ETF
PKB
$429M
$74.6K ﹤0.01%
1,828
+1,804
+7,517% +$73.1K
IUSG icon
2073
iShares Core S&P US Growth ETF
IUSG
$30.7B
$74.3K ﹤0.01%
912
-1,609
-64% -$134K
AGFS
2074
DELISTED
AgroFresh Solutions Inc
AGFS
$73.5K ﹤0.01%
+24,818
New +$62.2K
RSPM icon
2075
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$190M
$73.3K ﹤0.01%
+2,310
New +$73.2K

Similar funds

Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review

As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
  • Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
  • Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
  • Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
  • Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.